Clinical Trials Management System (CTMS) Market Widening Scope, Analysis And Forecasts To 2025 |Grand View Research, Inc
“The global Clinical Trials Management System (CTMS) market size was valued at USD 592.07 million in 2016. It is anticipated to expand at a CAGR of 12.1% over the forecast period.�
The global clinical trials management system (CTMS) market size is expected to reach USD 1.62 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 12.1% over the forecast period. Rapid growth of healthcare IT, high R&D expenditure by life science and clinical research organizations, and adoption of CTMS solutions is anticipated to drive the market growth. Increasing investment by pharmaceutical and biotechnology companies coupled with government funding is promoting research activities. This factor is expected to boostgrowth of the market for clinical trial management systems.According to the estimates of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), global research-based pharmaceutical industry has spent around USD 149.8 billion in 2015. The annual spending of pharmaceutical industry is 5.5 times greater than the aerospace industry, 1.8 times more than software and computer services andsoftware industry, and 5 times more than chemicals industry.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/clinical-trial-managementsystem-ctms-market
Follow Us:
Further key findings from the study suggest:
Enterprise CTMS held the largest market share in 2016 due to the benefits such as real-time insight into operational activities and efficient tracking in tracking and managing the regulatory process
Web-based systems held the largest market share in 2016 owing to the benefits such as remote access of data and minimal technical issues
Cloud based system is anticipated to exhibit the fastest CAGRover the forecast period. Real-time data tracking, high security, easy accessibility from any device, and privacy are a few factors attributed to the growth
Based onregion, North America is expected to continue holding the largest market share during the forecast period due to high adoption of advanced technology and improved healthcare infrastructure
Asia Pacificis likely to witness significant growthover the next decade due toincreasing government incentives and low cost of clinical trials
Some of the key players operating in the Clinical Trials Management System (CTMS) market are Surgery Partners;PARAXEL International Corporation; Oracle Corporation; Medidata Solutions Inc.; Forte Research Systems Inc.; Medpace Holdings Inc.; and Clinical Data Inc.
Grand View Research has segmented the global Clinical Trials Management System (CTMS) market based on type, delivery mode, component, end user, and region: Clinical Trials Management System (CTMS) Type Outlook (Revenue, USD Million, 2014 - 2025) Enterprise
Site
Clinical Trials Management System (CTMS) Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025) Web-based
Cloud-based
On-Premise
Clinical Trials Management System (CTMS) Component Outlook (Revenue, USD Million, 2014 - 2025) Software
Services
Clinical Trials Management System (CTMS) End-User Outlook (Revenue, USD Million, 2014 - 2025) Pharmaceutical and Biotechnology Firm
Follow Us:
o
Johnson & Johnson
o
Roche
o
Novartis
o
Pfizer
o
Merck
o
GlaxoSmithKline
o
Novo Nordisk
o
Amgen
o
Bristol Myesr Squibb
o
Sanofi
CROs
Medical Device Firm
Clinical Trials Management System (CTMS) Regional Outlook (Revenue, USD Million, 2014 - 2025) North America
o
U.S.
o
Canada
Europe o
Germany
o
U.K.
o
France
o
Italy
o
Spain
o
Russia
o
Belgium
o
Netherlands
Asia Pacific o
Japan
o
China
o
India
o
Thailand
o
Australia
o
Singapore
o
Malaysia
o
Indonesia
o
South Korea
o
Philippines
Latin America
Follow Us:

o
Brazil
o
Mexico
o
Argentina
Middle East & Africa o
South Africa
o
Saudi Arabia
o
United Arab Emirates
Browse Related Category Reports @ www.grandviewresearch.com/industry/healthcare-it Table of Content of Clinical Trials Management System (CTMS) Market Chapter 1 Methodology And Scope 1.1 Research Methodology 1.2 Research Scope And Assumptions 1.3 List Of Abbreviations Chapter 2 Executive Summary 2.1 Market Summary Chapter 3 Market Variables, Trends & Scope 3.1 Market Segmentation Chapter 4 Market Definitions Chapter 5 Industry Outlook 5.1 Market Variable Analysis 5.1.1 Increasing Investment On The R&D By The Healthcare Companies 5.1.2 Rise In The Number Of Clinical Trials Leading To The Increasing Adoption Of Ctms Solutions 5.1.3 Favorable Government Policies 5.1.4 Companies Providing Training To The Professionals 5.2 Market Restraint Analysis 5.2.1 Barriers To Access To Clinical Data 5.2.2 High Cost Of CTMS 5.2.3 Risk Of Theft Of Personal Data Chapter 6 Business Environment Analysis 6.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
Follow Us:
6.2 Porter’s Five Forces Analysis 6.3 Value Chain Analysis Chapter 7 Regulatory And Political Forces 7.1 Regulatory Landscape 7.1.1 List Of Factors/ Regulations By Country 7.1.1.1 U.S. 7.1.1.2 Europe 7.1.1.3 Asia Pacific 7.1.1.3.1 China 7.1.1.3.2 Japan 7.1.1.3.3 India 7.1.1.4 Middle East & Africa 7.1.1.4.1 Uae 7.1.1.4.2 Saudi Arabia 7.1.1.4.3 South Africa 7.1.1.5 Latin America 7.1.1.5.1 Brazil 7.1.1.5.2 Mexico 7.1.1.5.3 Argentina 7.2 Political Landscape; Current & Future Scenario 7.2.1 List Of Factors/ Regulations/ Nature Of Governments By Country 7.2.1.1 China 7.2.1.2 Brazil 7.2.1.3 Argentina Chapter 8 Type Business Analysis 8.1 Ctms Market: Type Movement Analysis 8.1.1 Enterprise 8.1.1.1 Enterprise Market Estimates And Forecast, 2014 - 2025 8.1.2 On-Site 8.1.2.1 On-Site Market Estimates And Forecast, 2014 - 2025 Chapter 9 Delivery Mode Business Analysis 9.1 Ctms Market: Delivery Mode Movement Analysis
Follow Us:
9.1.1 Web-Based 9.1.1.1 Web-Based Market Estimates And Forecast, 2014 - 2025 9.1.2 Cloud-Based 9.1.2.1 Cloud-Based Market Estimates And Forecast, 2014 - 2025 9.1.3 On-Premise 9.1.3.1 On-Premise Market Estimates And Forecast, 2014 - 2025 Chapter 10 Component Business Analysis 10.1 Ctms Market: Component Movement Analysis 10.1.1 Software 10.1.1.1 Software Market Estimates And Forecast, 2014 - 2025 10.1.2 Service 10.1.2.1 Service Market Estimates And Forecast, 2014 - 2025 Chapter 11 End-User Business Analysis 11.1 Ctms Market: End-User Movement Analysis 11.1.1 Pharmaceutical And Biotechnology Firms 11.1.1.1 Pharmaceutical And Biotechnology Firms Market Estimates And Forecast, 2014 - 2025 11.1.1.2 Johnson & Johnson 11.1.1.2.1. Johnson & Johnson Market Estimates And Forecast, 2014 - 2025 11.1.1.3 Roche 11.1.1.3.1. Roche Market Estimates And Forecast, 2014 - 2025 11.1.1. 4novartis 11.1.1.4.1. Novartis Market Estimates And Forecast, 2014 - 2025 11.1.1.5 Pfizer 11.1.1.5.1. Pfizer Market Estimates And Forecast, 2014 - 2025 11.1.1.6 Merck 11.1.1.6.1. Merck Estimates And Forecast, 2014 - 2025 11.1.1.7 Glaxosmithkline 11.1.1.7.1. Glaxosmithkline Market Estimates And Forecast, 2014 - 2025 11.1.1.8 Novo Nordisk 11.1.1.8.1. Novo Nordisk Market Estimates And Forecast, 2014 - 2025 11.1.1.9 Amgen 11.1.1.9.1. Amgen Market Estimates And Forecast, 2014 - 2025
Follow Us:
11.1.1.10 Bristol Myesr Squibb 11.1.1.10.1. Bristol Myesr Squibb Market Estimates And Forecast, 2014 - 2025 11.1.1.11 Sanofi 11.1.1.11.1. Sanofi Market Estimates And Forecast, 2014 - 2025 11.1.2 Clinical Research Organisations (Cros) 11.1.2.1 Cros Market Estimates And Forecast, 2014 - 2025 11.1.3 Medical Device Firms 11.1.3.1 Medical Device Firms Market Estimates And Forecast, 2014 - 2025 Chapter 12 Regional Business Analysis 12.1.Ctms Market: Regional Movement Analysis 12.1.1 North America 12.1.1.1 North America Market Estimates And Forecast, 2014 - 2025 12.1.1.2 U.S. 12.1.1.2.1 U.S. Market Estimates And Forecast, 2014 - 2025 12.1.1.3 Canada 12.1.1.3.1 Canada Market Estimates And Forecast, 2014 - 2025 12.1.2 Europe 12.1.2.1 Europe Market Estimates And Forecast, 2014 - 2025 12.1.2.2 Germany 12.2.2.1 Germany Market Estimates And Forecast, 2014 - 2025 12.1.2.3 U.K. 12.1.2.3.1 U.K. Market Estimates And Forecast, 2014 - 2025 12.1.2.4 France 12.1.2.4.1 France Market Estimates And Forecast, 2014 - 2025 12.1.2.5 Italy 12.1.2.5.1 Italy Market Estimates And Forecast, 2014 - 2025 12.1.2.6 Spain 12.1 2.6.1 Spain Market Estimates And Forecast, 2014 - 2025 12.1.2.7 Russia 12.1.2.7.1 Russia Market Estimates And Forecast, 2014 - 2025 12.1.2.8 Belgium 12.1.2.8.1 Belgium Market Estimates And Forecast, 2014 - 2025
Follow Us:
12.1.2.9 Netherlands 12.1.2.9.1 Netherlands Market Estimates And Forecast, 2014 - 2025 12.1.3 ASia-Pacific 12.1.3.1 Asia-Pacific Market Estimates And Forecast, 2014 - 2025 12.1.3.2 Japan 12.1.3.2.1 Japan Market Estimates And Forecast, 2014 - 2025 12.1.3.3 China. 12.1.3.3.1 China Market Estimates And Forecast, 2014 - 2025 12.1.3.4 India 12.1.3.4.1 India Market Estimates And Forecast, 2014 - 2025 12.1.3.5 Thailand 12.1.3.5.1 Thailand Market Estimates And Forecast, 2014 - 2025 12.1.3.6 Australia 12.1.3.6.1 Australia Market Estimates And Forecast, 2014 - 2025 12.1.3.7 Singapore 12.1.3.7.1 Singapore Market Estimates And Forecast, 2014 - 2025 12.1.3.8 Malaysia 12.1.3.8.1 Malaysia Market Estimates And Forecast, 2014 - 2025 12.1.3.9 Indonesia 12.1.3.9.1 Indonesia Market Estimates And Forecast, 2014 - 2025 12.1.3.10 South Korea 12.1.3.10.1 South Korea Market Estimates And Forecast, 2014 - 2025 12.1.3.11 Philippines 12.1.3.11.1 Philippines Market Estimates And Forecast, 2014 - 2025 12.1.4 Latin-AmericA 12.1.4.1 Latin America Market Estimates And Forecast, 2014 - 2025 12.1.4.2 Brazil 12.1.4.2.1 Brazil Market Estimates And Forecast, 2014 - 2025 12.1.4.3 Mexico 12.1.4.3.1 Mexico Market Estimates And Forecast, 2014 - 2025 12.1.4.4 Argentina 12.1.4.4.1 Argentina Market Estimates And Forecast, 2014 - 2025
Follow Us:
12.1.5 Middle East & Africa 12.1.5.1 Middle-East And Africa Market Estimates And Forecast, 2014 - 2025 12.1.5.2 Uae 12.1.5.2.1 Uae Market Estimates And Forecast, 2014 - 2025 12.1.5.3 Saudi Arabia. 12.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2014 - 2025 12.1.5.4 South Africa 12.1.5.4.1 South Africa Market Estimates And Forecast, 2014 - 2025 Chapter 13 Competitive Vendor Landscape 13.1 List Of Players Operating In The Market Chapter 14 Company Profile 14.1 Paraxel International Corporation 14.1.1 Company OverviEW 14.1.2 FInancial Performance 14.1.3 Geographic Foothold 14.1.4 Service Benchmarking 14.1.5 Strategic Initiatives 14.2 Oracle Corporation 14.2.1 Company Overview 14.2.2 Financial Performance 14.2.3 Geographic Foothold 14.2.4 Service Benchmarking 14.2.5 Strategic Initiatives 14.3 Medidata Solutions Inc. 14.3.1 Company Overview 14.3.2 Financial Performance 14.3.3 Geographic Foothold 14.3.4 Service Benchmarking 14.3.5 Strategic Initiatives 14.4 Forte Research Systems Inc. 14.4.1 Company Overview 14.4.2 Geographic Foothold
Follow Us:
14.4.3 Service Benchmarking 14.4.4 Strategic Initiatives 14.5 Medpace Holdings Inc. 14.5.1 Company Overview 14.5.2 Financial Performance 14.5.3 Service Benchmarking 14.5.4 Strategic Initiatives 14.6 Clinical Data Inc. 14.6.1 Company Overview 14.6.2 Geographic Foothold 14.6.3 Service Benchmarking 14.7 Bioclinica Inc 14.7.1 Company Overview 14.7.2 Geographic Foothold 14.7.3 Service Benchmarking 14.7.4 Strategic Initiatives 14.8 Datatrak International Inc. 14.8.1 Company Overview 14.8.2 Financial Performance 14.8.3 Service Benchmarking 14.8.4 Strategic Initiatives 14.9 G.Tec Medical Engineering Gmbh 14.9.1 Company Overview 14.9.2 Service Benchmarking 14.10 Bio-Optronics, Inc. 14.10.1 Company Overview 14.10.2 Service BenchmarkiNG 14.10.3 Strategic Initiatives 14.11 Veeva Systems Inc. 14.11.1 Company Overview 14.11.2 Service Benchmarking Chapter 15 Kol Commentary
Follow Us:
15.1 Key Insights 15.2 Kol Views Chapter 16 Recommendations
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: